4 Wojskowy SzpitaKliniczny Z Polikliniką Samodzielny Publiczny ZakładOpieki ZdrowotneWe Wrocławiu

The 4 Wojskowy SzpitaKliniczny Z Polikliniką Samodzielny Publiczny ZakładOpieki ZdrowotneWe Wrocławiu is conducting extensive studies in cardiovascular diseases, with a strong focus on heart failure, myocardial infarction, atrial fibrillation, and broader atherosclerotic disease. These trials are designed to test new therapies, improve symptom control, and reduce major cardiovascular events.

• Heart failure, reduced or preserved ejection fraction, and related structural heart disease
• Acute coronary syndromes, myocardial infarction, and cardiogenic shock
• Prevention of stroke, cardiovascular death, and other major adverse events

This portfolio also includes research on inflammation-linked cardiovascular risk, lipid-related risk factors, and treatment strategies aimed at improving outcomes in patients with advanced or high-risk cardiac conditions.

Another major area of research at this Wrocław site involves kidney disease, metabolic disorders, and systemic inflammation. Studies are exploring ways to slow disease progression, lower proteinuria, and improve risk reduction in patients with chronic conditions that often overlap with cardiovascular disease.

• Primary and secondary IgA nephropathy
• Chronic kidney disease with hypertension or cardiovascular risk
• Type 2 diabetes, obesity, and inflammation-related complications

These trials are focused on evaluating treatment effectiveness and safety, with the broader goal of preserving kidney function and improving long-term health in patients with complex renal and metabolic disease.

The site also supports clinical research in eye diseases and endocrine complications, including conditions that can affect vision and daily functioning. Investigators are studying new approaches to help improve disease control and patient outcomes in both chronic and progressive disorders.

• Thyroid eye disease
• Diabetic retinopathy
• Vision-threatening complications linked to diabetes and immune-related disease

These studies aim to assess whether emerging therapies can better protect eye health and reduce the burden of long-term complications associated with diabetes and thyroid-related disease.

Clinical trials in neurology at this institution include work on acute ischemic stroke and related cerebrovascular emergencies. The research is centered on improving early treatment options and evaluating whether new therapies can help limit brain injury and support recovery.

• Acute ischemic stroke and transient ischemic attack
• Intracerebral hemorrhage and other acute neurological events
• Stroke treatment options for patients with limited alternatives

These studies reflect a practical effort to expand treatment possibilities in urgent brain vascular disease and improve outcomes for patients seen in time-sensitive settings.

Research in digestive system diseases and immune-mediated conditions includes studies of ulcerative colitis and other inflammatory disorders. The purpose of these trials is to evaluate how well new treatments control symptoms, support remission, and improve quality of life.

• Moderate to severe active ulcerative colitis
• Inflammation-driven gastrointestinal disease
• Therapies aimed at improving remission and long-term disease control

These investigations add to the site’s broader focus on immune system diseases and treatment strategies that may offer better control of chronic inflammatory illness.

The site is involved in clinical trials across several neoplasms, including cancers of the lung, prostate, bladder, breast, head and neck, and colon. These studies are designed to test new cancer therapies, refine treatment planning, and assess whether combinations of treatments can improve outcomes.

• Metastatic and early-stage prostate cancer
• Non-small cell lung cancer and small cell lung cancer
• Bladder cancer, breast cancer, colorectal cancer, and head and neck cancer

This oncology portfolio includes both treatment-focused trials and studies supporting diagnosis or care planning, highlighting a broad commitment to advancing cancer research and patient-centered care.

In addition to its major disease programs, the research site also participates in studies covering psychiatry, male and female urogenital diseases, and selected pathological conditions. These projects broaden the site’s clinical research profile and address conditions with important quality-of-life implications.

• Psychosis associated with Alzheimer’s disease
• Erectile dysfunction and other urogenital disorders
• Venous thromboembolism prevention and other supportive care topics

Overall, the program reflects a diverse mix of therapeutic areas, with a strong emphasis on cardiology alongside complementary research in chronic disease management and symptom-focused care.